An investigation by the ABPI (Association of the British Pharmaceutical Industry)
D000676:Amrinone / Q000009:adverse effects; D004345:Drug Industry / Q000592:standards*; D006801:Humans; D012926:Social Control, Formal; D012957:Societies, Pharmaceutical; D006113:United Kingdom
D000676:Amrinone